Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an autoimmune disorder characterized by the progressive damage to the peripheral nerves, leading to weakness and sensory loss.

Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...

CIDP can be challenging to diagnose. Its presenting symptoms may be similar to other conditions affecting the nervous system, which include motor neuron disease, diabetic polyneuropathy ...

CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange, but new ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) affects the peripheral nerves. Tests to diagnose this condition include nerve conduction studies, electromyography, and sometimes an MRI.

Polyneuropathy occurs when multiple peripheral nerves become damaged. Symptoms include problems with sensation, coordination, or other body functions. Polyneuropathy is also known as peripheral ...

DNTH-103 is under clinical development by Dianthus Therapeutics and currently in Phase I for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase I drugs for ...

We explore the somewhat nebulous relationship between chronic inflammatory demyelinating polyneuropathy and cancer risk. Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized by ...

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are major complications that occur in severely ill patients who require intensive care treatment. CIP and CIM affect the ...

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment ...

Pregnancy largely affects disease activity and clinical course in women with immune-mediated neurological disorders. Chronic inflammatory demyelinating polyneuropathy (CIDP) is rare but the most ...